Clinical Trial Update: Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 pivotal trial evaluating CARTISTEM against a surgical comparator for knee cartilage defects and osteoarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Cartilage Defects
• Osteoarthritis of the Knee

Drugs mentioned

• CARTISTEM

Snippet

Sponsor: Medipost, Inc. | Conditions: Knee Cartilage Defects | Phase 3 | Status: RECRUITING